Samsung
Latest news, explainers and analysis on Samsung. Tracking 5 stories on Arth Vani.
Connected in the graph
Latest on Samsung
Samsung Backs Nvidia AI Chip Rival Euclyd with $230 Million Investment
Dutch startup Euclyd, a competitor to Nvidia in the AI chip market, has secured $230 million in a funding round co-led by Samsung. This significant investment highlights the growing interest in alternatives to Nvidia's dominant graphics processing units (GPUs) for artificial intelligence applications.
Samsung Warns Global Chip Shortage May Last Until 2028; Signs Long-Term Supply Deals
Samsung Electronics has reported a surge in semiconductor profits and warned that the global chip shortage could persist for the next four years. To mitigate risks, the tech giant has secured multi-year supply agreements with major global data center operators.
New LaunchBreakingSamsung Launches First Credit Card in US: Wallet-First Experience with Cash Rewards
Samsung has launched its first co-branded credit card, the Samsung Galaxy Card, in the U.S. Issued by Barclays on the Visa network, it offers cash rewards on eligible Samsung purchases, Samsung Wallet usage, streaming, and everyday spending. The card emphasizes a 'wallet-first' digital experience, being instantly provisioned to Samsung Wallet.
Samsung-Backed AI Chip Firm Rebellions Eyes South Korea IPO Next Year
Rebellions, an AI chip company backed by Samsung, is planning an Initial Public Offering (IPO) in South Korea next year. CEO Sunghyun Park indicated a preference for listing on the KOSPI exchange. This move highlights the growing investor interest in the artificial intelligence sector.
South Korea’s Kospi Plummets 9% as AI Chip Rally Crumbles; Lessons for Indian Investors
South Korea’s benchmark index faced a massive selloff on Monday, triggered by a rout in semiconductor giants like Samsung and SK Hynix. The crash led to a temporary trading halt, signaling a shift in global investor sentiment regarding AI-driven stocks.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.